Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2008 Sep 24.
Published in final edited form as: J Am Chem Soc. 2007 May 16;129(23):7272–7273. doi: 10.1021/ja072648i

Nanometer-Sized Amino Acids for the Synthesis of Nanometer-Scale Water-Soluble Molecular Rods of Precise Length

Chris M Gothard 1, Nosheen A Rao 1, James S Nowick 1,*
PMCID: PMC2552997  NIHMSID: NIHMS62392  PMID: 17503829

Abstract

This paper introduces the unnatural amino acid Abc2K as a nanometer-length building block for the creation of water-soluble molecular rods of exceptional size. Abc2K is a water-soluble variant of the unnatural amino acid 4’-amino-[1,1’-biphenyl]-4-carboxylic acid (Abc) with lysinelike propyloxyammonium side chains at the 2- and 5-positions. The protected building block Fmoc-Abc2K(Boc)-OH (1) can be used in standard Fmoc-based solid-phase peptide synthesis to create water-soluble rodlike peptides in nanometer unit lengths up to at least ten nanometers. Oligomers up to and including the decamer were easily prepared on a Rink amide resin. These peptides are easy to purify and characterize by standard reverse-phase HPLC, 1H NMR, and ESI-MS techniques. The Abc2K amino acid can be combined with various standard amino acids to provide well behaved hybrid and biologically relevant peptides. Building block 1 is efficiently prepared on a multigram scale from commercially available starting materials by way of the Suzuki cross-coupling reaction. Molecular modeling studies of Abc2K oligomers show only minor effects from torsional and bending motions and support a model in which the oligomers are relatively straight and rigid. Fluorescence resonance energy transfer (FRET) studies are consistent with a model in which the Abc2K oligomers behave as rigid rods with a length of 1.0 nm per monomer unit.


This paper introduces the unnatural amino acid Abc2K as a nanometer-length building block for the creation of water-soluble molecular rods in nanometer unit lengths up to at least ten nanometers. Over the past two decades, molecular rods have been developed that can be assembled in precise constitution and length from individual building blocks.14 Many of these oligomers, such as staffanes and oligo(p-phenylene ethynylene)s, require carbon-carbon bond formation for their synthesis and are designed to be soluble in organic solvents.1 Nucleic acids provide one attractive approach to water-soluble oligomers and have been used as rod-like components in a variety of architectures.2 Peptides and peptide derivatives provide a particularly attractive approach, both because of their biological compatibility and relevance, and because of their ease of assembly through widely available peptide synthesis technologies.3 Here, we introduce water-soluble rodlike peptides of exceptional size that are constructed from a 1.0-nm long θ-amino acid. These θ-peptides are easy to assemble and purify with standard peptide synthesis and purification technologies and can be combined with biologically relevant peptides.

graphic file with name nihms62392f5.jpg

We designed Abc2K as a water-soluble variant of the unnatural amino acid 4’-amino-[1,1’-biphenyl]-4-carboxylic acid (Abc) with lysinelike propyloxyammonium side chains at the 2- and 5-positions.5 The amino acid Abc2K is readily prepared as building block 1, with Fmoc protection of the aniline main chain and Boc protection of the side chains, to be compatible with standard Fmoc-based solid-phase synthesis. Molecular modeling studies of Abc2K oligomers show only minor effects from torsional and bending motions and support a model in which the oligomers are relatively straight and rigid. Monte Carlo-stochastic dynamics (MC/SD) studies of the decamer H-(Abc2K)10-OH in MacroModel with the AMBER* force field and GB/SA water solvation at 300 K show an average length of 10.1 nm with 0.5 nm standard deviation. Only if unstable cis-amide linkages are introduced does substantial bending of the rods occur. Chart 1 provides a molecular model of the decamer H-(Abc2K)10-OH.

Chart 1.

Chart 1

Molecular Model of Abc2K Decamer H-(Abc2K)10-OH

The Fmoc-Abc2K(Boc)-OH building block (1) is efficiently prepared on a multigram scale from commercially available 1,4-dibromo-2,5-dimethoxybenzene (2). Generation of a Grignard reagent from 2 followed by reaction with dry ice and acidic aqueous workup affords 4-bromo-2,5-dimethoxybenzoic acid (3). Cleavage of the methyl ether groups with aqueous HBr in AcOH provides 4-bromo-2,5-dihydroxybenzoic acid (4). Protection of the acid group as the phenacyl ester generates ester 5. Introduction of the Boc-3-aminopropoxy “K(Boc)” side chains by Williamson ether synthesis forms diether 6. Suzuki cross-coupling with 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline (6a) using 3–5 mol% PdCl2(dppf)•CH2Cl2 gives the biphenyl derivative H-Abc2K(Boc)-OCH2COPh (7). Fmoc-protection of the amino group of 7 affords Fmoc-Abc2K(Boc)-OCH2COPh (8). Finally, removal of the phenacyl group with Zn in aqueous AcOH provides Fmoc-Abc2K(Boc)-OH (1). Apart from the modest yield of the Grignard reaction, these reactions afford 76–95% yields and easily allow he preparation of 1 in ca. five-gram batches.

Fmoc-Abc2K(Boc)-OH (1) can be used like an ordinary Fmoc-protected amino acid in solid-phase peptide synthesis. Oligomers up to and including the decamer (9a–9i) were easily prepared on Rink amide resin and purified by reverse-phase HPLC (RP-HPLC). Coupling reactions were typically performed with 3 equivalents of 1 and 12-hr coupling times. Either HCTU and 2,4,6-collidine or diisopropylcarbodiimide and HOAt were used as coupling agents, with the former eventually being found preferable. The oligomers have good water solubility and are readily characterized by standard analytical techniques, such as RP-HPLC, ESI-MS, and 1H NMR spectroscopy in D2O solution. Figure 1 illustrates these data for hexamer 9f. The 1H NMR spectra of the oligomers are sharp at low concentrations but broaden at higher concentrations, suggesting that little or no aggregation occurs at tenth-millimolar concentrations but that self-association occurs at higher concentrations.

Figure 1.

Figure 1

Characterization data for the Abc2K hexamer H-(Abc2K)6-NH2 (9f): analytical RP-HPLC, ESI-MS, and 1H NMR spectroscopy.

graphic file with name nihms62392f6.jpg

Fluorescence resonance energy transfer (FRET) studies support a model in which the Abc2K oligomers behave as rigid rods with a length of 1.0 nm per monomer unit (Figure 2).3aef,6 For these studies, we designed a homologous series of oligomers containing the FRET donor and acceptor groups EDANS and Dabcyl linked to the amino acids Glu and Lys and separated by 1–10 Abc2K units [10a10j, Ac-Lys-Lys-Glu(EDANS)-(Abc2K)n-Lys(Dabcyl)-Lys-Lys-NH2, n = 1–10].7 We incorporated flanking Lys residues to enhance solubility and reduce aggregation, which proved to be problematic with the hydrophobic EDANS and Dabcyl groups.8 FRET studies were performed in 50% aqueous DMSO (to minimize aggregation of the longer oligomers) with 335 nm excitation and 400–600 nm detection. The oligomers exhibit increasing fluorescence with increasing length through the 8-mer 10h, with the largest increases occurring between the 4-mer (10d), 5-mer (10e), and 6-mer (10f). The 9-mer (10i) and 10-mer (10j) exhibit slight decreases and blue-shifting of the fluorescence.

Figure 2.

Figure 2

FRET study of peptides 10a–10j. (a) Fluorescence emission spectra of 1.75 µM solutions of the peptides in 50% aqueous DMSO solution with 335 nm excitation. (b) Fluorescence intensity at λmax.

The observed dependence of fluorescence on oligomer length is reasonably consistent with that predicted by the Förster equation [energy transfer efficiency = 1/(1 + R6/R06)].6 For the EDANS-Dabcyl pair, the Förster radius (R0) is 3.3 nm. If each Abc2K unit provides 1 nm separation (R) between the EDANS and Dabcyl groups, relatively little fluorescence is predicted for the 1- and 2-mers, substantially increasing fluorescence is predicted for the 3-, 4- and 5-mers, and nearly complete fluorescence is predicted for the 5- to 10-mers. The discrepancy between the predicted and observed fluorescence is consistent with the flexibility of the Glu and Lys tethers (ca. 1 nm) and is comparable to variations observed in a related system with a polyproline spacer.3f The slight decreasing fluorescence and blue-shifting of the 9-mer and 10-mer may reflect slight aggregation of these compounds.

The Abc2K amino acid can be combined with other amino acids using standard Fmoc-based peptide synthesis techniques to give well-behaved hybrid peptides. To demonstrate the ease of synthesizing and handling peptides containing both α-amino acids and Abc2K, we synthesized peptide 11, which contains two RGD units separated by a two-nanometer spacer composed of two Abc2K units. RP-HPLC analysis showed the crude peptide to be 79% pure, and purification proceeded smoothly by standard RP-HPLC techniques. The peptide is water soluble and easy to characterize by ESI-MS and 1H NMR spectroscopy. We anticipate that the size, water solubility, and ease of incorporation into peptides will make Abc2K attractive as a rigid linker in various biologically relevant applications.1f,3c,9

graphic file with name nihms62392f7.jpg

In conclusion, Abc2K oligomers constitute a new class of water-soluble molecular rods that can be synthesized in precise and defined lengths up to at least 10 nm in 1-nm increments. The Fmoc-Adc2K(Boc)-OH building block is compatible with standard solid-phase peptide synthesis techniques, and the resulting peptides are water soluble and compatible with analytical and purification techniques that are standard for peptides. The ease of assembly and handling of the Abc2K nanometer-scale molecular rods should permit researchers who are not highly skilled in organic chemistry to use these new architectural elements in areas such as nanotechnology, materials science, and cell biology.

Supplementary Material

si20070507_095. Supporting Information Available.

Synthetic procedures, NMR, ESI-MS, HPLC data, and other experimental details. This material is available free of charge via the Internet at http://pubs.acs.org.

Scheme 1.

Scheme 1

Synthesis of Fmoc-Abc2K(Boc)-OH (1)

Acknowledgement

We thank the NIH (GM-49076) and ACS-PRF (38986-AC1) for financial support. C. M. G thanks the UCI Institute for Brain Aging and Dementia for training grant support (NIA-5T32AG00096). N. A. R. thanks the Pakistan Higher Education Commission for fellowship support.

References

  • 1.(a) Tour JM. Chem. Rev. 1996;96:537–553. doi: 10.1021/cr9500287. [DOI] [PubMed] [Google Scholar]; (b) Schwab PFH, Levin MD, Michl J. Chem. Rev. 1999;99:1863–1933. doi: 10.1021/cr970070x. [DOI] [PubMed] [Google Scholar]; (c) Levin MD, Kaszynski P, Michl J. Chem. Rev. 2000;100:169–234. doi: 10.1021/cr990094z. [DOI] [PubMed] [Google Scholar]; (d) Tour JM. Acc. Chem. Res. 2000;33:791–804. doi: 10.1021/ar0000612. [DOI] [PubMed] [Google Scholar]; (e) Schwab PFH, Smith JR, Michl J. Chem. Rev. 2005;105:1197–1279. doi: 10.1021/cr040707u. [DOI] [PubMed] [Google Scholar]; (f) Sakai N, Mareda J, Matile S. Acc. Chem. Res. 2005;38:79–87. doi: 10.1021/ar0400802. [DOI] [PubMed] [Google Scholar]
  • 2.(a) Seeman NC. Angew. Chem., Int. Ed. Engl. 1998;37:3220–3238. doi: 10.1002/(SICI)1521-3773(19981217)37:23<3220::AID-ANIE3220>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]; (b) Chworos A, Severcan I, Koyfman AY, Weinkam P, Oroudjev E, Hansma HG, Jaeger L. Science. 2004;306:2068–2072. doi: 10.1126/science.1104686. [DOI] [PubMed] [Google Scholar]; (c) Rothemund PWK. Nature. 2006;440:297–302. doi: 10.1038/nature04586. [DOI] [PubMed] [Google Scholar]
  • 3.(a) Stryer L, Haugland RP. Proc. Natl. Acad. Sci. U.S.A. 1967;58:719–726. doi: 10.1073/pnas.58.2.719. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Cheng RP, Gellman SH, DeGrado WF. Chem. Rev. 2001;101:3219–3232. doi: 10.1021/cr000045i. [DOI] [PubMed] [Google Scholar]; (c) Arora PS, Ansari AZ, Best TP, Ptashne M, Dervan PB. J. Am. Chem. Soc. 2002;124:13067–13071. doi: 10.1021/ja0208355. [DOI] [PubMed] [Google Scholar]; (d) Levins CG, Schafmeister CE. J. Am. Chem. Soc. 2003;125:4702–4703. doi: 10.1021/ja0293958. [DOI] [PubMed] [Google Scholar]; (e) Levins CG, Schafmeister CE. J. Org. Chem. 2005;70:9002–9008. doi: 10.1021/jo051639u. [DOI] [PubMed] [Google Scholar]; (f) Schuler B, Lipman EA, Steinbach PJ, Kumke M, Eaton WA. Proc. Natl. Acad. Sci. U.S.A. 2005;102:2754–2759. doi: 10.1073/pnas.0408164102. [DOI] [PMC free article] [PubMed] [Google Scholar]; (g) König HM, Gorelik T, Kolb U, Kilbinger AFM. J. Am. Chem. Soc. 2007;129:704–708. doi: 10.1021/ja0672831. [DOI] [PubMed] [Google Scholar]
  • 4.Semetey V, Moustakas D, Whitesides GM. Angew. Chem., Int. Ed. 2006;45:588–591. doi: 10.1002/anie.200502991. [DOI] [PubMed] [Google Scholar]
  • 5.Neustadt BR, Smith EM, Lindo N, Nechuta T, Bronnenkant A, Wu A, Armstrong L, Kumar C. Bioorg. Med. Chem. Lett. 1998;8:2395–2398. doi: 10.1016/s0960-894x(98)00433-8. [DOI] [PubMed] [Google Scholar]
  • 6.Selvin PR. Methods Enzymol. 1995;246:300–334. doi: 10.1016/0076-6879(95)46015-2. [DOI] [PubMed] [Google Scholar]
  • 7.Wang GT, Krafft GA. Bioorg. Med. Chem. Lett. 1992;2:1665–1668. [Google Scholar]
  • 8.Richardson PL. Abbott Laboratories. Personal communication. 2006 [Google Scholar]
  • 9.(a) Strong LE, Kiessling LL. J. Am. Chem. Soc. 1999;121:6193–6196. [Google Scholar]; (b) Krishnamurthy VM, Semetey V, Bracher PJ, Shen N, Whitesides GM. J. Am. Chem. Soc. 2007;129:1312–1320. doi: 10.1021/ja066780e. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

si20070507_095. Supporting Information Available.

Synthetic procedures, NMR, ESI-MS, HPLC data, and other experimental details. This material is available free of charge via the Internet at http://pubs.acs.org.

RESOURCES